高度纯化多核苷酸与安慰剂治疗中重度痤疮瘢痕的前瞻性随机初步研究
结果显示仅PN-HPT组在治疗后1个月和3个月较基线显著改善,提示PN-HPT单药治疗安全有效,但需更大样本和更长随访验证。
要点
- PN-HPT单药治疗中重度萎缩性痤疮瘢痕在1个月和3个月较基线显著改善。
- 研究为双盲设计,注射医生和患者均不知晓分组。
- 样本量小(每组10例)且随访短,结论需更大队列验证。
核心结论
- PN-HPT单药治疗萎缩性痤疮瘢痕与安慰剂相比安全有效。
- 需更大样本和更长随访的前瞻性随机研究进一步验证临床疗效。
研究设计与样本
- PN-HPT组10例接受4.0 mL PN-HPT,对照组10例接受4.0 mL生理盐水。
主要发现
- 仅PN-HPT组在治疗后1个月和3个月较基线显著改善。
临床怎么用
- PN-HPT可作为中重度萎缩性痤疮瘢痕的单药治疗选择,但需向患者说明证据来自小样本初步研究。
局限性
- 作者指出需更大队列和更长随访研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Managing acne scars is a challenge and therapies are divided into nonsurgical and surgical. Highly Purified Technology Polynucleotides (PN-HPT) is a compound that contains a mixture of DNA polymers of different lengths. Numerous studies have shown that PN-HPT also serves as an energy source, thus influencing cellular growth and cell vitality. OBJECTIVES: The authors aimed to assess the improvement in dermal quality and acne scars after PN-HPT vs placebo according to Antera 3D and the patient responses to the patient satisfaction questionnaire after a comparison of pretreatment and posttreatment photographs at 1 and 3 months. METHODS: Included were women aged 30 to 50 years with grade 3 to 4 moderate-to-severe atrophic scars according to the Goodman classification; nonsmokers; and had not had active acne during the past 5 years. Ten patients (PN-HPT group) were treated with 4.0 mL of PN-HPT, and 10 patients (control) were treated with 4.0 mL of normal saline. All medical treatments were performed in a double-blinded manner; neither the injection doctor nor the patient knew if the PN-HPT or the placebo was being administered. RESULTS: Twenty women who fit the inclusion criteria were enrolled in this study. Only patients in the PN-HPT group improved significantly at 1 and 3 months after treatment compared with baseline. CONCLUSIONS: This prospective and randomized study showed that PN-HPT in monotherapy was safe and effective treatment for atrophic scar acne compared with placebo. Prospective and randomized studies will be necessary to investigate the clinical effectiveness in a larger cohort of patients and for a longer follow-up.
引用
- Araco A, Araco F. Preliminary Prospective and Randomized Study of Highly Purified Polynucleotide vs Placebo in Treatment of Moderate to Severe Acne Scars. Aesthet Surg J. 2021. PMID: 33755110. doi:10.1093/asj/sjab125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。